June 2026 FDA Recall Lacosamide by Annora Pharma Private Limited
D-0626-2026 - Presence of a Foreign Tablets

This Class II drug recall was voluntarily initiated by Annora Pharma Private Limited on June 4, 2026 for the product Lacosamide. The FDA reported the reason for recall as presence of a foreign tablets. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0626-2026

Reason for Recall
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Initiated
06-04-2026
Reported
07-01-2026
Quantity
31,392 60-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Annora Pharma Private Limited
Nationwide in the USA
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.

Batch or Lot Expiration Information

Lot# Lot: A253999, A254000, Expires: 09/30/2027.